Worrying late payments situation in Italy
This article was originally published in Clinica
Payment of pre-1995 invoices to Italian national health service suppliers has come to a near halt in many regions. Confusion reigns at present over who is responsible for paying debts accrued by local health authorities (USLs) before they became local health businesses at the beginning of 1995, as part of the Italian healthcare reform.
You may also be interested in...
Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.
Keeping Track: Approvals For Tazverik And Tepezza, Priority Reviews For Belantamab Mafodotin And Lynparza
The latest drug development news and highlights from our US FDA Performance Tracker.
Accelerated approval in epithelial sarcoma may de-risk the firm’s goals for approval of Tazverik in follicular lymphoma and other larger indications.